TrialAnnals of surgical oncology2022

A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial).

Martha E Teke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.